 |
|
| Chronology of China's fight against SARS since April 20 （4） |
| CCTV.COM 2003-05-01 14:05:40 |
|
April 23
Chinese President Hu Jintao expressed deep grief for the death of Deng Lianxian, a Guangzhou－based infectious diseases doctor, who died of SARS after being infected on duty. Hu also offered sympathy and commiseration to Deng's family. China, said Hu, would eventually win the war on SARS with the hard work and devotion of medical workers and the unity of the nation.
As of 8:00 p.m. April 22, the MOH reported a total of 2,305 confirmed SARS cases, of which 1,231 had been discharged from hospital. The fatalities were 106.
An urgent circular issued by the MOH urged relevant departments nationwide to strengthen the administration and supervision of anti－SARS disinfectant production, in a bid to maintain an adequate level of disinfectant supplies and their quality.
Beijing's anti－SARS task force sent out a total of 152 supervisors to the city's 147 major hospitals. The municipal government designated another eight hospitals for SARS treatment. In the earlier stage, six hospitals had been designated.
The Beijing municipal government decided to put some areas seriously affected by SARS under quarantine, which it said was intended to effectively stop SARS spreading and cut the way it spread.
The Chinese government decided to create a national task force to combat SARS, and a national fund of two billion yuan （243 million US dollars） for prevention and control of the disease. The moves were taken by the State Council at its executive meeting chaired by Premier Wen Jiabao. The task force, known as the SARS Control and Prevention Headquarters of the State Council, was to coordinate national efforts to combat the disease. Vice－Premier WuYi was appointed as commander－in－chief. Hua Jianmin, State Councilor and secretary general of the State Council, acted as deputy commander－in－chief. The fund would be used to finance the treatment of farmers and poor urban residents infected with SARS and to upgrade county－level hospitals and purchase SARS－related medical facilities in central and western China, and for research programs on the virus.
|
|
Editor: Liu Hongji Source:Xinhua
|
|
|
|
|
|
|
